○Izumi Maki1, Y. Amaishi1, Seina Inui1, Ryousuke Nagata1, Toshiaki Yoshikawa2, Yuki Kagoya2, Sachiko Okamoto1, Ryuji Enoki1 (1.Technology Development Center, Takara Bio Inc., 2.Division of Tumor Immunology, Institute for Advanced Medical Research, Keio University School of Medicine)
Session information
Oral Session
[O5] Oral Session 5"Viral vectors 2"
Tue. Sep 12, 2023 9:00 AM - 10:10 AM Room 3 (1008, 10F, OICC)
Chairs:Ken-ichiro Kosai(Department of Gene Therapy and Regenerative Medicine. Kagoshima University Graduate School of Medical and Dental Sciences. ),Hiroaki MIZUKAMI(Division of Genetic Therapeutics, Center for Molecular Medicine, Jichi Medical University)
○Junichi Takagi1, Emiko Mihara1, Anananuchatkul Teerapat2, Haruo Aikawa2, Hiroaki Suga2 (1.Institute for Protein Research, Osaka University, 2.Department of Chemistry, Graduate School of Science, The University of Tokyo)
○Kaho Takeichi, Toshikazu Nishie, Kumiko Uemura, Yoko Kudo, Shuhei Sakamoto, Toshiyuki Miura, Daishi Ishihara, Hideto Chono, Sachiko Okamoto, Tatsuji Enoki, Jyunichi Mineno (Takara Bio Inc.)
○Kenji Ohba1, Yoshihide Sehara1, Tatsuji Enoki2, Junichi Mineno2, Keiya Ozawa1, Hiroaki Mizukami1 (1.Division of Genetic Therapeutics, Center for Molecular Medicine, Jichi Medical University, 2.CDM Center, TAKARA Bio Inc, 3.Division of Genetic Therapeutics, Center for Molecular Medicine, Jichi Medical University)
○Masato Yamamoto1, Kari Jacobsen1, Masayuki Nakamura2 (1.University of Minnesota, 2.3M Corporation)
○Mikako Wada, Yuji Tsunekawa, Ken Sugo, Yukihiko Hirai, Guillermo Posadas-Herrera, Hiromi Hayashita-Kinoh, Takashi Okada (Division of Molecular and Medical Genetics, Center for Gene and Cell Therapy, The Institute of Medical Science, The University of Tokyo)
○Mitsuko Fukuhara1,2, Yasuo Tsunaka2, Aoba Matsushita2, Yuki Yamaguchi2, Risa Shibuya2, Takahiro Maruno1,2, Megumi Onaka1, Karin Bandoh2, Susumu Uchiyama1,2 (1.U-Medico Inc., 2.Osaka University)